Spectrum Pharmaceuticals Announces New Employment Inducement Grants for Commercial Staff Phosphate Investing
Spectrum Pharmaceuticals Receives Complete Response Letter from U.S. Food and Drug Administration for Poziotinib; Reaffirms Focus on the Commercialization of ROLVEDON injection Phosphate Investing
Silver Eagle Mines CEO: Positioned to Supply Raw, Direct-application Rock Phosphate for Organic Farming Phosphate Investing
Nutrien Prices Offering of an Aggregate of US$1 Billion of 2-Year and 3-Year Senior Notes Phosphate Investing
Nutrien Announces Release Dates for Third Quarter 2022 Results and Conference Call Phosphate Investing
